NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use on Monday recommended approval of AstraZeneca's tyrosine kinase inhibitor Tagrisso (osimertinib) as a ...
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Scientists have identified the following genes associated with carcinogenesis (the development of cancer) in the lungs. Mutations of the EGFR gene can alter the production of a protein called ...
Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation. The new drug application (NDA) of sunvozertinib in relapsed/refractory ...
Cambridge: AstraZeneca's Tagrisso (osimertinib) has been recommended for approval in the European Union (EU) for the treatment of adult patients with locally advanced, unresectable non-small cell lung ...
If you’re trying to add more protein to your diet—whether to help your muscles recover after a workout or simply to stop your stomach from growling hours before lunch—there’s no shortage ...